Introduction The use of effective and durable combination antiretroviral therapy, or highly active antiretroviral therapy (HAART) has allowed us to witness successful long-term control of viral replication and prevention of AIDS-defining complications in people living with HIV/AIDS (PLWHA). However, non-AIDS-related comorbidities began to emerge as a result of direct viral effects with ongoing inflammation and […]
Grace Chung-Yan LUI
MBChB(Hons), FHKAM(Medicine), FRCP(Edin)
Dr LUI is Assistant Professor of the Division of Infectious Diseases at The Chinese University of Hong Kong. Her research interests include aging and comorbidities in people living with HIV.
Introduction Worldwide, tuberculosis (TB) incidence has been declining at about 2% per year, while a quarter of the world’s population is infected with Mycobacterium tuberculosis (MTB). In 2017, there were 10.0 million new TB cases, of which 0.83-1.01 million (9%) were people living with HIV/AIDS (PLWHA). Out of 1.6 million TB deaths, 0.30 (0.27-0.33) million […]
The ageing population of PLWHA With the availability of effective and durable highly active anti-retroviral therapy (HAART), people living with HIV/AIDS (PLWHA) are having life expectancy approaching that of the general population. With the scale-up of HAART, the average age of PLWHA is increasing in both high and middle/low-income countries. Moreover, there is also a […]